- CRISPR-based genome editing system targets cancer cells and destroys them by genetic manipulation. A single treatment doubled the average life expectancy of mice with glioblastoma, improving their overall survival rate by 30%, and in metastatic ovarian cancer increased their survival rate by 80%. https://aftau.org/news_item/revolutionary-crispr-based-genome-editing-system-treatment-destroys-cancer-cells/ 465 comments science